MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA

Paras Kumar Mishra1, Naira Metreveli, Suresh C Tyagi

  • 1Department of Physiology & Biophysics, School of Medicine, University of Louisville, HSC -A -1215, 500S Preston Street, Louisville, KY 40202, USA. pkmish01@louisville.edu

Insights

Matrix metalloproteinase-9 (MMP-9) impairs cardiomyocyte function via proteinase-activated receptor-1 (PAR-1), but microRNAs and dicer influence sarcoplasmic reticulum calcium ATPase 2a (SERCA2a) expression, impacting cardiac contractility.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Biochemistry

Background:

  • Matrix metalloproteinase-9 (MMP-9) contributes to cardiomyocyte dysfunction.
  • Tissue inhibitor of metalloproteinase-4 (TIMP-4) can mitigate MMP-9 effects.
  • Proteinase-activated receptor-1 (PAR-1) signaling is implicated in MMP-9-induced cardiac issues, but mechanisms remain unclear.

Purpose of the Study:

  • To investigate if dicer induction and microRNA (miRNA) dysregulation contribute to sarcoplasmic reticulum calcium ATPase isoform 2a (SERCA2a) downregulation in MMP-9 and PAR-1-mediated cardiomyocyte dysfunction.
  • To elucidate the roles of MMP-9, TIMP-4, and PAR-1 in regulating cardiomyocyte contractility and calcium handling.

Main Methods:

  • Isolated ventricular cardiomyocytes from C57BL/6J mice and MMP-9 knockout (MMP-9KO) mice.
  • Treatment with MMP-9, TIMP-4, and PAR-1 antagonist.
  • Assessment of cardiomyocyte contractility and calcium transients using Ion Optics video-edge detection and Fura 2-AM.
  • Quantitative PCR for dicer, TIMP-4, and SERCA2a expression.
  • miRNA microarrays to compare expression profiles between MMP-9KO and control cardiomyocytes.

Main Results:

  • MMP-9 treatment reduced cardiomyocyte contraction and Ca(2+) transients, an effect blocked by PAR-1 antagonist.
  • TIMP-4 reversed MMP-9-induced inhibition of contraction and Ca(2+) transients.
  • MMP-9 knockout (MMP-9KO) cardiomyocytes exhibited enhanced contractility and Ca(2+) release compared to controls.
  • SERCA2a expression was upregulated, and dicer expression was inhibited in MMP-9KO myocytes.
  • Selective miRNA changes observed in MMP-9KO myocytes, including inhibition of miR-376b and overexpression of miR-1, miR-26a, miR-30d, and miR-181c.

Conclusions:

  • MMP-9 impairs cardiomyocyte function, partly mediated by PAR-1 signaling.
  • TIMP-4 acts as a protective factor against MMP-9-induced cardiac dysfunction.
  • Dicer and specific miRNAs play a role in regulating SERCA2a expression and cardiomyocyte calcium handling in response to MMP-9.
  • These findings reveal novel molecular mechanisms underlying MMP-9-related cardiac dysfunction involving miRNA-mediated regulation of SERCA2a.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...